Frank Herringer - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Independent Director

Mr. Frank C. Herringer is an Independent Director of Amgen Inc. Frank C. Herringer was a director of the Board of Transamerica Corporationrationration, a financial services company, since 1986, serving as Chairman of the board of directors from 1995 to December 2015. Mr. Herringer was an executive with Transamerica for 20 years, including its Chief Executive Officer from 1991 until its acquisition by Aegon N.V., a life insurance, pensions and asset management company, in 1999, subsequently serving on Aegons Executive Board for one year. Mr. Herringer was a director of Aegon U.S. Holding Corporationrationration from 1999 until its merger into Transamerica Corporationrationration in December 2015.
Age: 73  Director Since 2004      
805-447-1000  http://www.amgen.com
Herringer received an undergraduate degree and master?s degree in business administration from Dartmouth College.

Frank Herringer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Peter McDonnellAllergan plc
2015
Joel McCombBio Rad Laboratories Inc
2014
Jill SmithEndo International plc
2012
Sharad MansukaniEndo International plc
2017
Christopher BodineAllergan plc
2013
Ron TaylorAllergan plc
2013
David AltshulerVertex Pharmaceuticals Incorpor
2015
Joseph BoccuziAllergan plc
2017
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Christopher CoughlinAllergan plc
2016
James BloemAllergan plc
2013
Adriane BrownAllergan plc
2017
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Robert MalchioneBio Rad Laboratories Inc
2014
Robert AlpernAbbott Laboratories
2008
David GreenwayVertex Pharmaceuticals Incorpor
2017
Michael GallagherAllergan plc
2015
Deborah NeffBio Rad Laboratories Inc
2011
Shane CookeEndo International plc
2014
Roxanne AustinAbbott Laboratories
2000
Glenn TiltonAbbott Laboratories
2007

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Risk-Return Analysis Now
   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
Hide  View All  NextLaunch Risk-Return Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators